Table 2.
CTR Cohort: COP-Treated Subjects
| Code | Age (years) | Breed/sex | Classification | Use of steroids | Treatments recorded before chemotherapy | Use of dox |
|---|---|---|---|---|---|---|
| CTR 1 | 5 | German Shepherd, f | Centroblastic | No | SC: ceftriaxone; PO: doxycycline | Yes |
| CTR 2 | 5 | Mixed, m | Centroblastic | Yes | PO: doxycycline, prednisone, aspirin | Yes |
| CTR 3 | 6 | Bull Mastiff, f | Centroblastic | No | PO: clindamycin | Yes |
| CTR 4 | 4 | Bull Mastiff, m | Centroblastic | No | Gentamicin+betamethasone cutaneous ointment | Yes |
| CTR 5 | 12 | Mixed, f | Centroblastic/centrocytic | No | PO: enalapril | Yes |
| CTR 6 | 7 | English Setter, m | Pleomorphic | No | None | Yes |
| CTR 7 | 12 | German Shepherd, m | Centroblastic | Yes | PO: prednisone | Yes |
| CTR 8 | 1 | German Shepherd, f | Centroblastic | No | None | Yes |
| CTR 9 | 8 | Fox Terrier, f | Centroblastic | No | PO: metronidazole-spiramycin, furosemide | Yes |
| CTR 10 | 8 | Bull Terrier, m | Centroblastic | Yes | SC: rifamycin, methylprednisolone | Yes |
| CTR 11 | 13 | Mixed, m | Centroblastic | No | None | No |
| CTR 12 | 9 | German Shepherd, m | Centroblastic | No | None | No |
| CTR 13 | 9 | German Shepherd, f | Centroblastic | Yes | PO: amoxicillin-clavulanic acid, prednisone, ranitidine, S-adenosyl methionine | No |
| CTR 14 | 4 | Rottweiler, f | Lymphoblastic | Yes | PO: doxycycline, prednisone | Yes |
| CTR 15 | 10 | Doberman Pinscher, f | Centroblastic | No | PO: metronidazole | Yes |
| CTR 16 | 8 | Rottweiler, m | Centroblastic | No | None | Yes |
| CTR 17 | 8 | German Shepherd, fs | Centroblastic | No | PO: enrofloxacin | No |
| CTR 18 | 13 | Mixed, fs | Centroblastic | No | None | No |
| CTR 19 | 8 | Boxer, f | Centroblastic | No | None | Yes |
| CTR 20 | 7 | Great Dane, m | Centroblastic | Yes | PO: amoxicillin-clavulanic acid, prednisone | Yes |
| CTR 21 | 7 | Beagle, m | Centroblastic | No | PO: amoxicillin-clavulanic acid, enalapril | Yes |
CTR, COP arm.